Associated tags: Fraud, Action Replay, Trailblazer, News, Tobacco, Person, Hagens Berman, SAN, Pharmaceutical industry, Life insurance, Cryptocurrency, NYSE
Locations: SEATTLE, WA, US, FLORIDA, UTAH, OHIO, OREGON, TWIST, CALIFORNIA, PE, STALEY, ROCHESTER, JEFFRIES, LATIN AMERICA, BRAZIL, INDIA, CAO, OM, BRIGHTON, EMERSON, BLACKSTONE, WALL STREET, BROWNS, EU, LEAH, SCHNEIDER, III, SPAC, UAE, DISTRICT OF COLUMBIA, GW, UNITED STATES, CHINA, EUROPE, MASSACHUSETTS
SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial attorney firm, is urging investors who suffered substantial losses in Plug Power Inc. (NASDAQ: PLUG) to take action by submitting your losses here .
Key Points:
- SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial attorney firm, is urging investors who suffered substantial losses in Plug Power Inc. (NASDAQ: PLUG) to take action by submitting your losses here .
- Securities Fraud Class Action Against Plug Power Inc. (NASDAQ: PLUG): The lawsuit challenges Plug Power’s claims that its green hydrogen production plant construction was “on track” and that it had identified non-dilutive funding opportunities.
- The complaint alleges that Plug Power made misleading statements and failed to disclose the following:
Overstated Ability: Plug overstated its ability to mitigate the negative impacts of supply chain constraints and material shortages on its hydrogen business.
- “We are investigating whether Plug may have deceived investors about the sufficiency of its liquidity,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.
FDA,
Cirrhosis,
EFX,
Liver disease,
News,
Risk,
Fatty liver disease,
NASH,
Patient,
Failure,
Hagens Berman,
Clinical trial,
Therapy,
SAN,
Person,
Pharmaceutical industry SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to take action by submitting your losses now .
Key Points:
- SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to take action by submitting your losses now .
- Akero Therapeutics, Inc. (AKRO) Securities Fraud Class Action:
Akero Therapeutics, a biopharmaceutical company developing treatments for liver disease, is facing a securities class action lawsuit over allegations it misled investors about a key clinical trial.
- The lawsuit centers on the SYMMETRY study, designed to evaluate efruxifermin ("EFX"), Akero's lead drug candidate, for treating nonalcoholic steatohepatitis (NASH), a serious liver condition.
- "We are investigating whether Akero intentionally misrepresented its SYMMETRY patient population," stated Reed Kathrein, the Hagens Berman partner leading the investigation.
Steps,
Gold,
Mining,
Hagens Berman,
Court,
SSR,
SSRM,
Safety,
SAN,
Miner,
Risk,
Cryptocurrency SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman alerts investors in SSR Mining Inc. (NASDAQ: SSRM) of a class-action securities lawsuit.
Key Points:
- SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman alerts investors in SSR Mining Inc. (NASDAQ: SSRM) of a class-action securities lawsuit.
- The lawsuit seeks to recover losses on behalf of investors who purchased SSR Mining securities between Feb. 23 2022 and Feb. 27, 2024 and were adversely affected by the alleged fraud.
- If you suffered a loss in SSR Mining between these dates, you have until May 17, 2024 to request that the Court appoint you as lead plaintiff.
- If you invested in SSR Mining and have substantial losses, submit your losses now »
If you’d like more information about the SSR Mining case and our investigation, read more »
SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman alerts investors in Malibu Boats, Inc. (NASDAQ: MBUU) of a class-action securities lawsuit.
Key Points:
- SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman alerts investors in Malibu Boats, Inc. (NASDAQ: MBUU) of a class-action securities lawsuit.
- The lawsuit seeks to recover losses on behalf of investors who purchased Malibu securities between Nov. 4, 2022 and Apr.
- If you suffered a loss in Malibu between these dates, you have until June 28, 2024 to request that the Court appoint you as lead plaintiff.
- If you invested in Malibu Boats and have substantial losses, submit your losses now »
If you’d like more information about the Malibu Boats case and our investigation, read more »
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Shoals Technologies Group, Inc. (NASDAQ: SHLS) investors who suffered substantial losses to submit your losses now .
Key Points:
- SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Shoals Technologies Group, Inc. (NASDAQ: SHLS) investors who suffered substantial losses to submit your losses now .
- In particular, Shoals said wire shrinkback affected 30% of harnesses the company installed during 2020 – 2022 and booked a $50.2 million warranty expense related to the shrinkback issue.
- In response to this news, the price of Shoals shares fell $3.28 (over 20%) over the next two trading days.
- “We’re investigating whether Shoals intentionally understated its cost of revenues while concealing the extent of its wire shrinkback problems,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges The Chemours Company (NYSE: CC) investors who suffered substantial losses to submit your losses now .
Key Points:
- SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges The Chemours Company (NYSE: CC) investors who suffered substantial losses to submit your losses now .
- The Chemours Company (NYSE: CC) Securities Fraud Class Action:
“We’re investigating the propriety of Chemours’ financial statements, including its internal controls, and the company’s tone at the top,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
- Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
- For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .
EQIX,
Real estate investment trust,
AI,
Machine learning,
Hindenburg Research,
The Insider,
Hindenburg,
Bank statement,
REIT,
Hagens Berman,
Person Investors began to learn the truth on Mar.
Key Points:
- Investors began to learn the truth on Mar.
- In response to these events, the price of Equinix shares has fallen sharply lower.
- “We’re investigating whether Equinix may have inflated key financial metrics to appear more profitable,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
- Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Comtech Telecommunications Corp. (NASDAQ: CMTL) investors who suffered substantial losses to take action by submitting your losses here .
Key Points:
- SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Comtech Telecommunications Corp. (NASDAQ: CMTL) investors who suffered substantial losses to take action by submitting your losses here .
- The “One Comtech” Strategy Unravels: Under the leadership of CEO Ken Peterman, Comtech had championed the “One Comtech” strategy, which aimed to unify the company’s previously independent and siloed businesses.
- 13, 2024 Comtech announced that it would not timely file its quarterly financial statements with the U.S. Securities and Exchange Commission (SEC).
- This disclosure triggered another sharp decline in the company’s stock, with shares falling by $1.57 (27%) on the same day.
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Luna Innovations Incorporated (NASDAQ: LUNA) investors who suffered substantial losses to submit your losses now .
Key Points:
- SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Luna Innovations Incorporated (NASDAQ: LUNA) investors who suffered substantial losses to submit your losses now .
- Luna Innovations Incorporated (LUNA) Securities Fraud Class Action:
Luna Innovations, the Roanoke-based fiber optics company, is in freefall.
- On May 1, 2024, just after the market closed, Luna announced the abrupt departures of both its Chief Technology Officer, Brian Soller, and its Chief Financial Officer, George Gomez-Quintero.
- “We are digging deeper into the potential fraud in light of Luna’s most recent disclosure, considering a longer class period,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
News,
Safety,
The Wall Street Journal,
Osteoarthritis,
Cat,
ZTS,
Fatality,
Pet,
Dog,
Hagens Berman,
SAN,
Knowledge,
Person,
Pharmaceutical industry Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to contact the firm’s attorneys.
Key Points:
- Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to contact the firm’s attorneys.
- The investigation centers around Zoetis’ arthritis drugs, specifically Librela™ and Solensia™, which are designed to alleviate painful osteoarthritis in dogs and cats, respectively.
- Historically, these products have been significant revenue drivers for Zoetis’ companion animal division, with the company projecting peak sales of over $1 billion for its osteoarthritis pain franchise.
- “We are investigating whether Zoetis may have misrepresented the safety of its pet arthritis drugs,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
